GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Monday morning. The ...

Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Nevro's HFX spinal cord stimulation platform (SCS) includes the Senza SCS system. It offers support services for chronic pain treatment of limbs and trunks, as well as painful diabetic neuropathy.